Atlas Trials

Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease

Clinical trial NCT01309997 · COMPLETED

Trial details

NCT number
NCT01309997
Sponsor
Lee, Stephanie
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Graft Versus Host DiseaseSystemic Scleroderma
Start date
2011-03-01
Primary completion
2014-12-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.